Location History:
- Bengaluru, IN (2015)
- Hosur, IN (2014 - 2024)
Company Filing History:
Years Active: 2014-2025
Title: Innovations and Contributions of Kandhasamy Sarkunam
Introduction
Kandhasamy Sarkunam is a notable inventor based in Hosur, India, recognized for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, he has made remarkable advancements in drug development and therapeutic applications.
Latest Patents
Among his latest patents, Sarkunam has developed substituted amide compounds that serve as farnesoid X receptor modulators. These compounds are designed to modulate the activity of the farnesoid X receptor (FXR) and are useful in treating various diseases associated with FXR dysregulation, including pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders. Another significant patent involves tricyclic heteroaryl compounds that act as IRAK4 inhibitors. These compounds are aimed at treating, preventing, or slowing inflammatory and autoimmune diseases, as well as cancer.
Career Highlights
Sarkunam is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that address critical health challenges.
Collaborations
Throughout his career, Sarkunam has collaborated with esteemed colleagues, including Kishore V Renduchintala and Pulicharla Nagalakshmi, who is a prominent woman in the field.
Conclusion
Kandhasamy Sarkunam's innovative work and numerous patents highlight his dedication to advancing medical science and improving patient outcomes. His contributions are invaluable to the pharmaceutical industry and the broader field of healthcare.